BIKTARVY (Gilead Sciences, Inc.)
(https://biktarvy.com) 📸 Data Snapshot: May 29, 2026Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Information density is split between high-fluff marketing headings and high-substance clinical specifications. Headings like ‘Built for the Journey’ and ‘Resistance Matters’ provide zero technical value, scoring high on fluff saturation, but this is offset by specific body text containing exact dosage requirements (31 pounds) and pill dimensions (15 mm x 8 mm). Repetition is high due to compliance-mandated Important Safety Information (ISI) blocks appearing on every page, which, while necessary, dilutes the unique informational value of the sub-pages.
Information Density is read straight from the body copy: how much of the text carries grounded, checkable substance versus hollow filler. Below is the clean text the engine analyzed, then the industry’s known generic-claim patterns to weigh it against.
📝 The Narrative — clean text per page (the substance-vs-filler signal)
HOMEPAGE (https://biktarvy.com) BIKTARVY® | A One-Pill, Once-a-Day HIV Treatment Option
[IMG: Phil is smiling.] [IMG: You Are Unlike Any Other.] HIV doesn't have to change WHO YOU ARE or your plans People featured are compensated by Gilead. [H1] Ask Your Healthcare Provider About BIKTARVY®, the #1 Prescribed HIV Treatment for Over 6 Years* Source: IQVIA LAAD, May 2019 to December 2025.* Hear from real people on BIKTARVY as they open up about their journey living with HIV. [IMG: Click the image to watch real stories.] Explore real stories [IMG: Click the image to watch real conversations.] Hear real conversations [IMG: A hand holding a pill next to a pill bottle.] [H2] Starting HIV Treatment Learn about HIV treatment with once-daily BIKTARVY. How to take BIKTARVY [IMG: Maricela and her family are standing outside at a celebration.] [H2] BIKTARVY Is Tried and Tested With You In Mind Whether you're 18 or 80, BIKTARVY was studied in people from many different backgrounds. See BIKTARVY studies [IMG: Animated BIKTARVY pill with blue background.] [H2] Built for the Journey Designed with 3 powerful medicines that work to attack the virus. See how BIKTARVY works [IMG: A man crouched beside his daughter on her bike.] [H2] Resistance Matters Learn about HIV drug resistance and how BIKTARVY was studied with resistance in mind. Learn more about resistance [IMG: Denise is singing into a microphone.] [H2] Been on HIV treatment before? If you're ready to begin HIV treatment again, talk with your healthcare provider. They can guide you through your options and next steps. Learn about restarting HIV treatment with BIKTARVY [IMG: Phil video play button.] Check out the latest commercial Your browser doesn't support HTML5 video tag. [H4] What is HIV? Get the facts about HIV with this general overview. Learn about HIV [H4] Can I live healthy with HIV? There are steps you can take to help you live healthy with HIV. Ways to live healthy with HIV *This information is an estimate derived from the use of information under license from the following IQVIA information service: IQVIA LAAD, for the period May 2019 through December 2025. IQVIA expressly reserves all rights, including rights of copying, distribution, and republication. [H2] What is BIKTARVY®? Expand [IMG: expand button] Collapse [IMG: collapse button] BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 31 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who have received HIV-1 medicines in the past, or to replace their current HIV-1 medicines, and whose healthcare provider determines they meet certain requirements. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS. Tap for Important Safety Information for BIKTARVY, including an important warning on worsening of hepatitis B. [IMG: Open Important Safety Information] [IMG: open-indication] [IMG: close-indication] IMPORTANT SAFETY INFORMATION [H2] What is BIKTARVY? BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 31 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who have received HIV-1 medicines in the past, or to replace their current HIV-1 medicines, and whose healthcare provider determines they meet certain requirements. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS. [H2] IMPORTANT SAFETY INFORMATION [H3] What is the most important information I should know about BIKTARVY? BIKTARVY may cause serious side effects: Worsening of hepatitis B (HBV). Your healthcare provider will test you for HBV. If you have both HIV-1 and HBV and stop taking BIKTARVY, your HBV may suddenly get worse. Do not stop taking BIKTARVY without first talking to your healthcare provider, as they will need to monitor your health, and may give you HBV medicine. [H3] Who should not take BIKTARVY? Do not take BIKTARVY if you take: dofetilide rifampin any other medicines to treat HIV-1 [H3] What are the other possible side effects of BIKTARVY? Serious side effects of BIKTARVY may also include: Changes in your immune system. Your immune system may get stronger and begin to fight infections that may have been hidden in your body. Tell your healthcare provider if you have any new symptoms after you start taking BIKTARVY. Kidney problems, including kidney failure. Your healthcare provider should do blood and urine tests to check your kidneys. If you develop new or worse kidney problems, they may tell you to stop taking BIKTARVY. Too much lactic acid in your blood (lactic acidosis), which is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat. Severe liver problems, which in rare cases can lead to death. Tell your healthcare provider right away if you get these symptoms: skin or the white part of your eyes turns yellow, dark “tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, or stomach-area pain. The most common side effects of BIKTARVY in clinical studies were diarrhea (6%), nausea (6%), and headache (5%). Tell your healthcare provider if you have any side effects that bother you or don’t go away. [H3] What should I tell my healthcare provider before taking BIKTARVY? All your health problems. Be sure to tell your healthcare provider if you have or have had any kidney or liver problems, including hepatitis virus. All the medicines you take, including prescription and over-the-counter medicines, antacids, laxatives, vitamins, and herbal supplements. BIKTARVY and other medicines may affect each other. Keep a list of all your medicines and show it to your healthcare provider and pharmacist, and ask if it is safe to take BIKTARVY with all of your other medicines. If you are pregnant or plan to become pregnant. Tell your healthcare provider if you become pregnant while taking BIKTARVY. If you are breastfeeding (nursing) or plan to breastfeed. Talk to your healthcare provider about the risks of breastfeeding during treatment with BIKTARVY. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see Important Facts about BIKTARVY, including important warnings. [H2] What is BIKTARVY? BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 31 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who have received HIV-1 medicines in the past, or to replace their current HIV-1 medicines, and whose healthcare provider determines they meet certain requirements. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS. [H2] IMPORTANT SAFETY INFORMATION [H3] What is the most important information I should know about BIKTARVY? BIKTARVY may cause serious side effects: Worsening of hepatitis B (HBV). Your healthcare provider will test you for HBV. If you have both HIV-1 and HBV and stop taking BIKTARVY, your HBV may suddenly get worse. Do not stop taking BIKTARVY without first talking to your healthcare provider, as they will need to monitor your health, and may give you HBV medicine. [H3] Who should not take BIKTARVY? Do not take BIKTARVY if you take: dofetilide rifampin any other medicines to treat HIV-1 [H3] What are the other possible side effects of BIKTARVY? Serious side effects of BIKTARVY may also include: Changes in your immune system. Your immune system may get stronger and begin to fight infections that may have been hidden in your body. Tell your healthcare provider if you have any new symptoms after you start taking BIKTARVY. Kidney problems, including kidney failure. Your healthcare provider should do blood and urine tests to check your kidneys. If you develop new or worse kidney problems, they may tell you to stop taking BIKTARVY. Too much lactic acid in your blood (lactic acidosis), which is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat. Severe liver problems, which in rare cases can lead to death. Tell your healthcare provider right away if you get these symptoms: skin or the white part of your eyes turns yellow, dark “tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, or stomach-area pain. The most common side effects of BIKTARVY in clinical studies were diarrhea (6%), nausea (6%), and headache (5%). Tell your healthcare provider if you have any side effects that bother you or don’t go away. [H3] What should I tell my healthcare provider before taking BIKTARVY? All your health problems. Be sure to tell your healthcare provider if you have or have had any kidney or liver problems, including hepatitis virus. All the medicines you take, including prescription and over-the-counter medicines, antacids, laxatives, vitamins, and herbal supplements. BIKTARVY and other medicines may affect each other. Keep a list of all your medicines and show it to your healthcare provider and pharmacist, and ask if it is safe to take BIKTARVY with all of your other medicines. If you are pregnant or plan to become pregnant. Tell your healthcare provider if you become pregnant while taking BIKTARVY. If you are breastfeeding (nursing) or plan to breastfeed. Talk to your healthcare provider about the risks of breastfeeding during treatment with BIKTARVY. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see Important Facts about BIKTARVY, including important warnings. [H2] What is BIKTARVY? BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 31 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who have received HIV-1 medicines in the past, or to replace their current HIV-1 medicines, and whose healthcare provider determines they meet certain requirements. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS.
SUB-PAGE (https://biktarvy.com/real-stories/) Real Patient Stories | BIKTARVY®
[IMG: Maricela and her family are standing outside at a celebration.] People featured are compensated by Gilead. [H2] Genuine Voices. Real Experiences. Get to know some of the people who take BIKTARVY®. Listen to their voices, watch their stories, and see their unique experiences living with HIV. [IMG: Maricela and her family are standing outside at a celebration.] People featured are compensated by Gilead. [H2] Genuine Voices. Real Experiences. Get to know some of the people who take BIKTARVY®. Listen to their voices, watch their stories, and see their unique experiences living with HIV. [IMG: Chad holding onto a bar and standing.] [H3] Chad Started in 2018 Chad followed his dreams from rural Kentucky to New York. Meet Chad [IMG: denise-singing] [H3] Denise Switched in 2019 Denise shows that passion and intimacy have no age limit. Meet Denise [IMG: D’Eva holding flowers.] [H3] D’Eva Switched in 2018 Finding community, love, and purpose, D’Eva is taking her power back. Meet D’Eva [IMG: Dimitri leaning on partner and looking at the view.] [H3] Dimitri Started in 2018 New York tries to keep up with Dimitri as he helps others. Meet Dimitri [IMG: Elias hiking outside.] [H3] Elias Switched in 2018 Living in San Francisco has always been a dream for Elias. Meet Elias [IMG: Hugo smiling at the dining table.] [H3] Hugo Switched in 2018 A lifelong student, Hugo is a man of faith and science. Meet Hugo [IMG: Dimitri is smiling in conversation with someone.] [H2] Real Conversations Real people share their experiences and thoughts about living with HIV. Explore real conversations [IMG: maricela-smiling-gazing] [H3] Maricela Switched in 2018 For Maricela, family is everything. Meet Maricela [IMG: Melanie looking to the side.] [H3] Melanie Switched in 2018 Melanie began a journey of empowerment and advocacy by courageously sharing her HIV status. Meet Melanie [IMG: Nikki singing.] [H3] Nikki Switched in 2018 Nikki found her voice and now helps others do the same. Meet Nikki [IMG: phil-smiling-friends] [H3] Phil Switched in 2018 Volunteering put Phil on a path to higher education and helping others. Meet Phil [IMG: Tamera smiling among other people.] [H3] Tamera Started in 2018 Tamera turns challenges into opportunities for growth and understanding. Meet Tamera [IMG: theron-towel] [H3] Theron Switched in 2020 Home is where the heart is for Theron and his husband, David. Meet Theron [IMG: Zach is outside with people.] [H3] Zach Switched in 2019 Zach’s newest adventure? Fatherhood. Meet Zach [H6] You may also be interested in: About BIKTARVY How BIKTARVY Works Support & Resources Help Paying for BIKTARVY Real Stories & Conversations Real Conversations [H2] What is BIKTARVY®? Expand [IMG: expand button] Collapse [IMG: collapse button] BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 31 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who have received HIV-1 medicines in the past, or to replace their current HIV-1 medicines, and whose healthcare provider determines they meet certain requirements. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS. Tap for Important Safety Information for BIKTARVY, including an important warning on worsening of hepatitis B. [IMG: Open Important Safety Information] [IMG: open-indication] [IMG: close-indication] IMPORTANT SAFETY INFORMATION [H2] What is BIKTARVY? BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 31 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who have received HIV-1 medicines in the past, or to replace their current HIV-1 medicines, and whose healthcare provider determines they meet certain requirements. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS. [H2] IMPORTANT SAFETY INFORMATION [H3] What is the most important information I should know about BIKTARVY? BIKTARVY may cause serious side effects: Worsening of hepatitis B (HBV). Your healthcare provider will test you for HBV. If you have both HIV-1 and HBV and stop taking BIKTARVY, your HBV may suddenly get worse. Do not stop taking BIKTARVY without first talking to your healthcare provider, as they will need to monitor your health, and may give you HBV medicine. [H3] Who should not take BIKTARVY? Do not take BIKTARVY if you take: dofetilide rifampin any other medicines to treat HIV-1 [H3] What are the other possible side effects of BIKTARVY? Serious side effects of BIKTARVY may also include: Changes in your immune system. Your immune system may get stronger and begin to fight infections that may have been hidden in your body. Tell your healthcare provider if you have any new symptoms after you start taking BIKTARVY. Kidney problems, including kidney failure. Your healthcare provider should do blood and urine tests to check your kidneys. If you develop new or worse kidney problems, they may tell you to stop taking BIKTARVY. Too much lactic acid in your blood (lactic acidosis), which is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat. Severe liver problems, which in rare cases can lead to death. Tell your healthcare provider right away if you get these symptoms: skin or the white part of your eyes turns yellow, dark “tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, or stomach-area pain. The most common side effects of BIKTARVY in clinical studies were diarrhea (6%), nausea (6%), and headache (5%). Tell your healthcare provider if you have any side effects that bother you or don’t go away. [H3] What should I tell my healthcare provider before taking BIKTARVY? All your health problems. Be sure to tell your healthcare provider if you have or have had any kidney or liver problems, including hepatitis virus. All the medicines you take, including prescription and over-the-counter medicines, antacids, laxatives, vitamins, and herbal supplements. BIKTARVY and other medicines may affect each other. Keep a list of all your medicines and show it to your healthcare provider and pharmacist, and ask if it is safe to take BIKTARVY with all of your other medicines. If you are pregnant or plan to become pregnant. Tell your healthcare provider if you become pregnant while taking BIKTARVY. If you are breastfeeding (nursing) or plan to breastfeed. Talk to your healthcare provider about the risks of breastfeeding during treatment with BIKTARVY. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see Important Facts about BIKTARVY, including important warnings. [H2] What is BIKTARVY? BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 31 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who have received HIV-1 medicines in the past, or to replace their current HIV-1 medicines, and whose healthcare provider determines they meet certain requirements. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS. [H2] IMPORTANT SAFETY INFORMATION [H3] What is the most important information I should know about BIKTARVY? BIKTARVY may cause serious side effects: Worsening of hepatitis B (HBV). Your healthcare provider will test you for HBV. If you have both HIV-1 and HBV and stop taking BIKTARVY, your HBV may suddenly get worse. Do not stop taking BIKTARVY without first talking to your healthcare provider, as they will need to monitor your health, and may give you HBV medicine. [H3] Who should not take BIKTARVY? Do not take BIKTARVY if you take: dofetilide rifampin any other medicines to treat HIV-1 [H3] What are the other possible side effects of BIKTARVY? Serious side effects of BIKTARVY may also include: Changes in your immune system. Your immune system may get stronger and begin to fight infections that may have been hidden in your body. Tell your healthcare provider if you have any new symptoms after you start taking BIKTARVY. Kidney problems, including kidney failure. Your healthcare provider should do blood and urine tests to check your kidneys. If you develop new or worse kidney problems, they may tell you to stop taking BIKTARVY. Too much lactic acid in your blood (lactic acidosis), which is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat. Severe liver problems, which in rare cases can lead to death. Tell your healthcare provider right away if you get these symptoms: skin or the white part of your eyes turns yellow, dark “tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, or stomach-area pain. The most common side effects of BIKTARVY in clinical studies were diarrhea (6%), nausea (6%), and headache (5%). Tell your healthcare provider if you have any side effects that bother you or don’t go away. [H3] What should I tell my healthcare provider before taking BIKTARVY? All your health problems. Be sure to tell your healthcare provider if you have or have had any kidney or liver problems, including hepatitis virus. All the medicines you take, including prescription and over-the-counter medicines, antacids, laxatives, vitamins, and herbal supplements. BIKTARVY and other medicines may affect each other. Keep a list of all your medicines and show it to your healthcare provider and pharmacist, and ask if it is safe to take BIKTARVY with all of your other medicines. If you are pregnant or plan to become pregnant. Tell your healthcare provider if you become pregnant while taking BIKTARVY. If you are breastfeeding (nursing) or plan to breastfeed. Talk to your healthcare provider about the risks of breastfeeding during treatment with BIKTARVY. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see Important Facts about BIKTARVY, including important warnings. [H2] What is BIKTARVY? BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 31 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who have received HIV-1 medicines in the past, or to replace their current HIV-1 medicines, and whose healthcare provider determines they meet certain requirements. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS.
SUB-PAGE (https://biktarvy.com/real-stories/real-conversations/) HIV Stories From Real People
[IMG: Dimitri and Chad are having a conversation.] People featured are compensated by Gilead. [H2] Find Inspiration in Every Conversation One of the ways we can defeat stigma is by having open conversations about some of the challenges of living with HIV, such as finding support, sharing status, facing barriers, and addressing mental health. [IMG: Real conversations play button.] “There is something about each of my peers that I can draw from.” Your browser doesn't support HTML5 video tag. [H3] Explore the series [IMG: Zach and Stina video play button.] “You made me find the strength within myself.” Your browser doesn't support HTML5 video tag. [H3] ZACH & STINA The day Zach walked out of the doctor’s office with his diagnosis, his mom, Stina, was there to encourage and support him. [IMG: Dimitri and Chad video play button.] “It’s wild to me that my HIV is what is bringing us together.” Your browser doesn't support HTML5 video tag. [H3] DIMITRI & CHAD Dimitri and Chad discuss how they each shared their status with their family and how their families supported them. Some states may have partner notification, which means if you test positive for HIV, you may be obligated to tell your partner(s). Explore more information here on how to navigate those policies. [IMG: D’Eva and Hugo video play button.] “There’s a lot of barriers. Language—el lenguaje es muy importante.” Your browser doesn't support HTML5 video tag. [H3] D’EVA & HUGO D’Eva and Hugo discuss some of the stigma and barriers that can affect those living with HIV in the Hispanic community and how to reach out in a meaningful way. [IMG: Chad and Dimitri video play button.] “Know that it’s human to ask for help.” Your browser doesn't support HTML5 video tag. [H3] CHAD & DIMITRI What would you say to someone newly diagnosed with HIV? Dimitri and Chad give thoughts on processing the diagnosis and talk about the importance of mental health. Your mental health is important at all points along your journey of living with HIV. Make sure you are taking time for yourself whenever you need to. And if you need help, it’s important to ask for help. If you need additional support, see below for some support resources. [H2] Help Is Out There Whether you’re newly diagnosed or have been living with HIV for a long time, we all need support. Sometimes, it may not even be about HIV. Or you may not know where to begin. Whatever the case, here are some important resources for you or anyone you know who may need help: National Suicide Prevention Lifeline (800) 273-8255 National Domestic Violence Hotline (800) 799-7233 National Sexual Assault Hotline (800) 656-4673 Substance Abuse and Mental Health National Helpline (800) 662-4357 The Trevor Project (for LGBTQ Youth) (866) 488-7386 Mental Health Resources HIV Disclosure Policies and Procedures HIV-Related Discrimination Resources [H4] What is BIKTARVY? Whether you’re starting, restarting, or switching, BIKTARVY is just one pill, once a day. Learn more [IMG: Zach is looking straight ahead.] “As time has gone on, I’ve realized that stigma was something that I put on myself.” –Zach [H6] You may also be interested in: About BIKTARVY BIKTARVY Studies Support & Resources Help Paying for BIKTARVY About BIKTARVY Restarting Treatment With BIKTARVY [H2] What is BIKTARVY®? Expand [IMG: expand button] Collapse [IMG: collapse button] BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 31 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who have received HIV-1 medicines in the past, or to replace their current HIV-1 medicines, and whose healthcare provider determines they meet certain requirements. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS. Tap for Important Safety Information for BIKTARVY, including an important warning on worsening of hepatitis B. [IMG: Open Important Safety Information] [IMG: open-indication] [IMG: close-indication] IMPORTANT SAFETY INFORMATION [H2] What is BIKTARVY? BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 31 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who have received HIV-1 medicines in the past, or to replace their current HIV-1 medicines, and whose healthcare provider determines they meet certain requirements. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS. [H2] IMPORTANT SAFETY INFORMATION [H3] What is the most important information I should know about BIKTARVY? BIKTARVY may cause serious side effects: Worsening of hepatitis B (HBV). Your healthcare provider will test you for HBV. If you have both HIV-1 and HBV and stop taking BIKTARVY, your HBV may suddenly get worse. Do not stop taking BIKTARVY without first talking to your healthcare provider, as they will need to monitor your health, and may give you HBV medicine. [H3] Who should not take BIKTARVY? Do not take BIKTARVY if you take: dofetilide rifampin any other medicines to treat HIV-1 [H3] What are the other possible side effects of BIKTARVY? Serious side effects of BIKTARVY may also include: Changes in your immune system. Your immune system may get stronger and begin to fight infections that may have been hidden in your body. Tell your healthcare provider if you have any new symptoms after you start taking BIKTARVY. Kidney problems, including kidney failure. Your healthcare provider should do blood and urine tests to check your kidneys. If you develop new or worse kidney problems, they may tell you to stop taking BIKTARVY. Too much lactic acid in your blood (lactic acidosis), which is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat. Severe liver problems, which in rare cases can lead to death. Tell your healthcare provider right away if you get these symptoms: skin or the white part of your eyes turns yellow, dark “tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, or stomach-area pain. The most common side effects of BIKTARVY in clinical studies were diarrhea (6%), nausea (6%), and headache (5%). Tell your healthcare provider if you have any side effects that bother you or don’t go away. [H3] What should I tell my healthcare provider before taking BIKTARVY? All your health problems. Be sure to tell your healthcare provider if you have or have had any kidney or liver problems, including hepatitis virus. All the medicines you take, including prescription and over-the-counter medicines, antacids, laxatives, vitamins, and herbal supplements. BIKTARVY and other medicines may affect each other. Keep a list of all your medicines and show it to your healthcare provider and pharmacist, and ask if it is safe to take BIKTARVY with all of your other medicines. If you are pregnant or plan to become pregnant. Tell your healthcare provider if you become pregnant while taking BIKTARVY. If you are breastfeeding (nursing) or plan to breastfeed. Talk to your healthcare provider about the risks of breastfeeding during treatment with BIKTARVY. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see Important Facts about BIKTARVY, including important warnings. [H2] What is BIKTARVY? BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 31 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who have received HIV-1 medicines in the past, or to replace their current HIV-1 medicines, and whose healthcare provider determines they meet certain requirements. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS. [H2] IMPORTANT SAFETY INFORMATION [H3] What is the most important information I should know about BIKTARVY? BIKTARVY may cause serious side effects: Worsening of hepatitis B (HBV). Your healthcare provider will test you for HBV. If you have both HIV-1 and HBV and stop taking BIKTARVY, your HBV may suddenly get worse. Do not stop taking BIKTARVY without first talking to your healthcare provider, as they will need to monitor your health, and may give you HBV medicine. [H3] Who should not take BIKTARVY? Do not take BIKTARVY if you take: dofetilide rifampin any other medicines to treat HIV-1 [H3] What are the other possible side effects of BIKTARVY? Serious side effects of BIKTARVY may also include: Changes in your immune system. Your immune system may get stronger and begin to fight infections that may have been hidden in your body. Tell your healthcare provider if you have any new symptoms after you start taking BIKTARVY. Kidney problems, including kidney failure. Your healthcare provider should do blood and urine tests to check your kidneys. If you develop new or worse kidney problems, they may tell you to stop taking BIKTARVY. Too much lactic acid in your blood (lactic acidosis), which is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat. Severe liver problems, which in rare cases can lead to death. Tell your healthcare provider right away if you get these symptoms: skin or the white part of your eyes turns yellow, dark “tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, or stomach-area pain. The most common side effects of BIKTARVY in clinical studies were diarrhea (6%), nausea (6%), and headache (5%). Tell your healthcare provider if you have any side effects that bother you or don’t go away. [H3] What should I tell my healthcare provider before taking BIKTARVY? All your health problems. Be sure to tell your healthcare provider if you have or have had any kidney or liver problems, including hepatitis virus. All the medicines you take, including prescription and over-the-counter medicines, antacids, laxatives, vitamins, and herbal supplements. BIKTARVY and other medicines may affect each other. Keep a list of all your medicines and show it to your healthcare provider and pharmacist, and ask if it is safe to take BIKTARVY with all of your other medicines. If you are pregnant or plan to become pregnant. Tell your healthcare provider if you become pregnant while taking BIKTARVY. If you are breastfeeding (nursing) or plan to breastfeed. Talk to your healthcare provider about the risks of breastfeeding during treatment with BIKTARVY. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see Important Facts about BIKTARVY, including important warnings. [H2] What is BIKTARVY? BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 31 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who have received HIV-1 medicines in the past, or to replace their current HIV-1 medicines, and whose healthcare provider determines they meet certain requirements. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS.
SUB-PAGE (https://biktarvy.com/about-biktarvy/) What Is BIKTARVY® & How Does It Work?
[IMG: A hand holding a BIKTARVY pill.] Not actual size (15 mm x 8 mm) [H2] Learn More About the #1 Prescribed HIV Treatment for Over 6 Years* Not actual size (15 mm x 8 mm) Source: IQVIA LAAD, May 2019 through December 2025.* Nearly 500,000 people in the United States take BIKTARVY for their HIV treatment. Source: IQVIA LAAD, March 2021 through July 2025.† BIKTARVY is a complete HIV-1 treatment that combines 3 powerful medicines into 1 small pill, taken once a day with or without food. BIKTARVY should not be taken with other HIV-1 medicines. BIKTARVY is a prescription medicine for adults and children with HIV-1 who weigh at least 31 pounds and who: are new to treatment have received HIV-1 medicines in the past OR are replacing their current HIV-1 medicines For adults and children who have received HIV-1 medicines in the past or are replacing their current HIV-1 medicines, their healthcare provider must determine if they meet certain requirements. Children weighing at least 31 pounds to less than 55 pounds take a lower-dose tablet of BIKTARVY containing 30 mg bictegravir, 120 mg emtricitabine, and 15 mg tenofovir alafenamide once daily with or without food. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS. [IMG: Tamera is smiling with a man.] People featured are compensated by Gilead. Whether you're starting HIV treatment for the first time, restarting, or switching, ask your healthcare provider about the most prescribed* HIV treatment and if it’s right for you. *This information is an estimate derived from the use of information under license from the following IQVIA information service: IQVIA LAAD, for the period May 2019 through December 2025. IQVIA expressly reserves all rights, including rights of copying, distribution, and republication. †This information is an estimate derived from the use of information under license from the following IQVIA information service: IQVIA LAAD, for the period March 2021 through July 2025. IQVIA expressly reserves all rights, including rights of copying, distribution, and republication. [H6] Please see Important Safety Information about BIKTARVY, including an important warning on hepatitis B. [IMG: Dimitri is on the phone at a desk.] Person featured is compensated by Gilead. [H2] How BIKTARVY Works [H3] Built to Start Fast The medicines in BIKTARVY were designed to attack the virus right away and lower the amount of HIV in your blood to undetectable levels. Undetectable is when the amount of virus in your blood is below the level that can be measured in a lab test (less than 50 copies/mL). According to the US Department of Health and Human Services (DHHS), many patients can get to undetectable in as quickly as 8 to 24 weeks, when taking their treatment as prescribed. Some people are even able to start treatment the same day as diagnosis. [H3] The medicines in BIKTARVY work quickly to fight the virus. [IMG: Illustration of Descovy (emtricitabine and tenofovir alafenamide) pill.] Please see Important Facts about BIKTARVY ® and DESCOVY ®, including important warnings. [H5] Considering BIKTARVY? Download the BIKTARVY brochure to learn more. Buscas información en español? Visita BIKTARVY.com/espanol [H6] You may also be interested in: About BIKTARVY BIKTARVY Studies About BIKTARVY Possible Side Effects About BIKTARVY Restarting Treatment With BIKTARVY [H2] What is BIKTARVY®? Expand [IMG: expand button] Collapse [IMG: collapse button] BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 31 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who have received HIV-1 medicines in the past, or to replace their current HIV-1 medicines, and whose healthcare provider determines they meet certain requirements. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS. Tap for Important Safety Information for BIKTARVY, including an important warning on worsening of hepatitis B. [IMG: Open Important Safety Information] [IMG: open-indication] [IMG: close-indication] IMPORTANT SAFETY INFORMATION [H2] What is BIKTARVY? BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 31 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who have received HIV-1 medicines in the past, or to replace their current HIV-1 medicines, and whose healthcare provider determines they meet certain requirements. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS. [H2] IMPORTANT SAFETY INFORMATION [H3] What is the most important information I should know about BIKTARVY? BIKTARVY may cause serious side effects: Worsening of hepatitis B (HBV). Your healthcare provider will test you for HBV. If you have both HIV-1 and HBV and stop taking BIKTARVY, your HBV may suddenly get worse. Do not stop taking BIKTARVY without first talking to your healthcare provider, as they will need to monitor your health, and may give you HBV medicine. [H3] Who should not take BIKTARVY? Do not take BIKTARVY if you take: dofetilide rifampin any other medicines to treat HIV-1 [H3] What are the other possible side effects of BIKTARVY? Serious side effects of BIKTARVY may also include: Changes in your immune system. Your immune system may get stronger and begin to fight infections that may have been hidden in your body. Tell your healthcare provider if you have any new symptoms after you start taking BIKTARVY. Kidney problems, including kidney failure. Your healthcare provider should do blood and urine tests to check your kidneys. If you develop new or worse kidney problems, they may tell you to stop taking BIKTARVY. Too much lactic acid in your blood (lactic acidosis), which is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat. Severe liver problems, which in rare cases can lead to death. Tell your healthcare provider right away if you get these symptoms: skin or the white part of your eyes turns yellow, dark “tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, or stomach-area pain. The most common side effects of BIKTARVY in clinical studies were diarrhea (6%), nausea (6%), and headache (5%). Tell your healthcare provider if you have any side effects that bother you or don’t go away. [H3] What should I tell my healthcare provider before taking BIKTARVY? All your health problems. Be sure to tell your healthcare provider if you have or have had any kidney or liver problems, including hepatitis virus. All the medicines you take, including prescription and over-the-counter medicines, antacids, laxatives, vitamins, and herbal supplements. BIKTARVY and other medicines may affect each other. Keep a list of all your medicines and show it to your healthcare provider and pharmacist, and ask if it is safe to take BIKTARVY with all of your other medicines. If you are pregnant or plan to become pregnant. Tell your healthcare provider if you become pregnant while taking BIKTARVY. If you are breastfeeding (nursing) or plan to breastfeed. Talk to your healthcare provider about the risks of breastfeeding during treatment with BIKTARVY. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see Important Facts about BIKTARVY, including important warnings. [H2] What is BIKTARVY? BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 31 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who have received HIV-1 medicines in the past, or to replace their current HIV-1 medicines, and whose healthcare provider determines they meet certain requirements. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS. [H2] IMPORTANT SAFETY INFORMATION [H3] What is the most important information I should know about BIKTARVY? BIKTARVY may cause serious side effects: Worsening of hepatitis B (HBV). Your healthcare provider will test you for HBV. If you have both HIV-1 and HBV and stop taking BIKTARVY, your HBV may suddenly get worse. Do not stop taking BIKTARVY without first talking to your healthcare provider, as they will need to monitor your health, and may give you HBV medicine. [H3] Who should not take BIKTARVY? Do not take BIKTARVY if you take: dofetilide rifampin any other medicines to treat HIV-1 [H3] What are the other possible side effects of BIKTARVY? Serious side effects of BIKTARVY may also include: Changes in your immune system. Your immune system may get stronger and begin to fight infections that may have been hidden in your body. Tell your healthcare provider if you have any new symptoms after you start taking BIKTARVY. Kidney problems, including kidney failure. Your healthcare provider should do blood and urine tests to check your kidneys. If you develop new or worse kidney problems, they may tell you to stop taking BIKTARVY. Too much lactic acid in your blood (lactic acidosis), which is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat. Severe liver problems, which in rare cases can lead to death. Tell your healthcare provider right away if you get these symptoms: skin or the white part of your eyes turns yellow, dark “tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, or stomach-area pain. The most common side effects of BIKTARVY in clinical studies were diarrhea (6%), nausea (6%), and headache (5%). Tell your healthcare provider if you have any side effects that bother you or don’t go away. [H3] What should I tell my healthcare provider before taking BIKTARVY? All your health problems. Be sure to tell your healthcare provider if you have or have had any kidney or liver problems, including hepatitis virus. All the medicines you take, including prescription and over-the-counter medicines, antacids, laxatives, vitamins, and herbal supplements. BIKTARVY and other medicines may affect each other. Keep a list of all your medicines and show it to your healthcare provider and pharmacist, and ask if it is safe to take BIKTARVY with all of your other medicines. If you are pregnant or plan to become pregnant. Tell your healthcare provider if you become pregnant while taking BIKTARVY. If you are breastfeeding (nursing) or plan to breastfeed. Talk to your healthcare provider about the risks of breastfeeding during treatment with BIKTARVY. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see Important Facts about BIKTARVY, including important warnings. [H2] What is BIKTARVY? BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 31 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who have received HIV-1 medicines in the past, or to replace their current HIV-1 medicines, and whose healthcare provider determines they meet certain requirements. BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS.
🧭 Industry Context — common generic-claim patterns in Medical Devices, Pharma & Biotech to weigh the text against
This page presents a snapshot of public data from BIKTARVY (Gilead Sciences, Inc.), captured on May 29, 2026, to show how machine logic reads Information Density signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to BIKTARVY (Gilead Sciences, Inc.): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://biktarvy.com to view the most current version of its content and see directly what this company is about and what it offers.